SBIR and STTR grants: how federal non-dilutive research funding works

Federal SBIR and STTR programs provide non-dilutive capital to startups, allowing them to fund early research without trading away equity or intellectual property [1, 2]. Two primary programs—Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)—serve as key channels for early-stage capital, operating collectively as America's Seed Fund [1, 2]. Because these awards take zero equity and leave all patents in founder hands, they remain a foundational alternative to venture investment ^[2].

What are the SBIR and STTR programs?

The SBIR and STTR initiatives exist to provide early-stage technology capital for commercial small businesses ^[1]. Congress establishes the overarching legislative rules, yet every participating federal agency runs its own specialized program branch ^[1]. Central oversight stems from the Small Business Administration (SBA), whose team oversees the Policy Directive and acts as a direct liaison connecting startups with government agencies ^[1].

Participating entities include organizations such as the National Science Foundation (NSF), which has supported early ventures under this structure since 1977 ^[2]. Branded in part as America's Seed Fund powered by NSF, this branch backs approximately 400 small firms annually ^[2]. It deliberately engages both repeat founders and first-time entrepreneurs operating across all 50 states ^[2].

What are the funding amounts and statutory limits?

Funding rolls out through structured sequential stages, primarily Phase I feasibility and Phase II prototype scale-up [1, 2]. The SBA periodically resets standard limits governing how much funding an agency can grant without formal exceptions ^[1]. As of Oct. 16, 2026, agencies may issue awards up to the following levels ^[1]:

| Phase | Standard Ceiling | Approval Condition |
| :--- | :--- | :--- |
| Phase I | $335,937 | No SBA approval required |
| Phase II | $2,239,578 | No SBA approval required |

These dollar thresholds cover baseline awards along with all project modifications ^[1]. If a contracting department wants to grant funding that surpasses these caps, it must secure an official waiver under Policy Directive §7(i)(4) ^[1].

How does government grant capital compare to private equity?

The defining characteristic of America's Seed Fund is its strictly non-dilutive nature ^[2]. The government takes no ownership stake, meaning entrepreneurs preserve complete authority over corporate governance, staffing decisions, and intellectual property ^[2].

Instead of evaluating investor returns or quick liquidity paths, agency reviewers assess proposals across core technical criteria ^[2]. Applications are measured primarily by the project's technical inventiveness, commercial market viability, and broader societal impact ^[2].

What technologies and industries receive backing?

Awards target ventures that conduct R&D in deep tech—technologies built directly on core discoveries in science and engineering ^[2]. Areas of application span almost every technical category, including artificial intelligence, medical devices, energy, semiconductors, and robotics ^[2]. Examples of backed small businesses include:

• Grain Weevil, a company constructing a mobile agricultural robot that handles grain bins, helping protect farm workers and maintain crop quality ^[2].
• Via Separations, which develops specialized graphene oxide membranes designed for industrial separation systems ^[2].
• Soctera Inc, which engineers thermally optimized gallium nitride (GaN) radio-frequency power amplifiers to address thermal and transmission barriers across 5G, telecom, radar, and rural broadband networks ^[2].
• Curie Co, a startup engineering bio-based materials via microbial precision fermentation, providing safe alternatives to FDA-restricted chemicals in cosmetics and fabrics ^[2].
• Electra, an industrial outfit combining chemistry and renewable power to convert raw iron ore into 99% pure refined iron ^[2].
• Biomedical and software companies, including Path Ex's blood pathogen filtering device, Kintsugi Mindful Wellness's AI voice diagnostic tool, Tambo's targeted disease drug activation method, and Prisms of Reality's immersive virtual reality math learning software ^[2].